A New Approach to Cancer Treatment?
This groundbreaking study was published in the Journal of Orthomolecular Medicine (Volume 39, Number 3) on September 19, 2024. The research presents a new and radically different approach to cancer treatment by targeting the Mitochondrial-Stem Cell Connection (MSCC).
Key Theory
The study introduces the MSCC hypothesis, which combines metabolic and cancer stem cell theories. It proposes that cancer originates from impaired oxidative phosphorylation (OxPhos) in stem cells, leading to the formation of cancer stem cells (CSCs) and subsequent malignancy.
Protocol Components
The researchers developed a 12-week treatment protocol combining:
Primary Interventions
Intravenous Vitamin C (1.5g/kg/day, 2-3x per week)
Vitamin D (up to 50,000 IU/day based on blood levels)
Zinc (1 mg/kg/day)
Ivermectin (0.5-2 mg/kg based on cancer grade)
Benzimidazoles (Mebendazole or Fenbendazole)
Supporting Therapies
Ketogenic diet
Strategic fasting
Moderate physical activity
Hyperbaric oxygen therapy (for advanced cases)
Scientific Basis
The protocol targets cancer through multiple mechanisms:
Restoring mitochondrial function
Eliminating cancer stem cells
Blocking cancer's primary fuel sources (glucose and glutamine)
Targeting metastasis formation
Conclusion
This represents the first peer-reviewed protocol combining these specific interventions for cancer treatment. The approach is different and at least better on paper because it addresses both bulk cancer cells and cancer stem cells, whereas traditional therapies often fail to target CSCs effectively.